Ironwood Receives $75M from Astellas for IBS Drug
The Cambridge, Mass.-based company has signed a $75 million deal with Astella Pharmaceuticals to market Ironwood’s IBS drug in Asia.
forest laboratories
Brocair Publishes New Report on Generics Market
Brocair Partners LLC, an investment bank serving the healthcare industry, has published a new report on the generic pharmaceuticals sector.